← Back to Search
Staged vs Simultaneous Knee Replacement for Osteoarthritis
Montréal, Canada
N/A
Waitlist Available
Led By Eric R. Bohm, MD
Research Sponsored by Orthopaedic Innovation Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients considering bilateral knee arthroplasty
Be older than 18 years old
Must not have
Patients who require simultaneous bilateral knee replacement surgery in order to manage significant bilateral flexion or valgus knee contractures where staged procedures may result in suboptimal outcomes by increasing the risk of post-operative flexion contracture in the 'first replaced' knee
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial will help answer the question of whether it is better to have both knees replaced at the same time or to do one and wait to do the second one.
See full description
Who is the study for?
This trial is for individuals considering bilateral knee arthroplasty, who are able to sign a consent form and willing to complete study questionnaires. It's not suitable for those unable to fill out the questionnaires or who need simultaneous surgery due to severe knee contractures.Check my eligibility
What is being tested?
The study aims to determine whether it's better for patients with osteoarthritis to have both knees replaced at once (simultaneous) or one at a time (staged). Participants will be assigned one of these two surgical approaches.See study design
What are the potential side effects?
Potential side effects from either surgical approach may include pain, swelling, infection risk, blood clots, stiffness in the knee joint, and complications related to anesthesia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am considering surgery for both of my knees.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need both knees replaced at the same time due to severe knee issues.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Veterans Rand 12-item Health Survey Score (VR-12)
Secondary study objectives
Complications
Costs of knee replacement surgery
Hospital stay
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Unicompartmental Knee Arthroplasty (UKA)Active Control2 Interventions
Patient will have half-knee replacement (partial) - Simultaneous vs Staged
Group II: Total Knee Arthroplasty (TKA)Active Control2 Interventions
Patient will have complete replacement - Simultaneous vs Staged
Find a Location
Closest Location:McGill University· Montréal, Canada
Who is running the clinical trial?
Orthopaedic Innovation CentreLead Sponsor
6 Previous Clinical Trials
446 Total Patients Enrolled
3 Trials studying Osteoarthritis
215 Patients Enrolled for Osteoarthritis
Eric R. Bohm, MDPrincipal InvestigatorUniversity of Manitoba
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need both knees replaced at the same time due to severe knee issues.I am considering surgery for both of my knees.I am willing to fill out study questionnaires for the study duration.
Research Study Groups:
This trial has the following groups:- Group 1: Unicompartmental Knee Arthroplasty (UKA)
- Group 2: Total Knee Arthroplasty (TKA)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.